| View |
|
DRHR-2183
|
Isopropyl Alcohol
|
Bodyguard
|
70% (v/v)
|
Solution
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
10 January 2023
|
10 January 2025
|
| View |
|
DRHR-2182
|
Isopropyl Alcohol
|
Riteguard
|
70% (v/v)
|
Solution
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
10 January 2023
|
10 January 2025
|
| View |
|
DRHR-2192
|
Isopropyl Alcohol
|
St. Gabriel
|
70% (v/v)
|
Solution
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
10 January 2023
|
10 January 2025
|
| View |
|
DRP-13224
|
Paracetamol
|
Ferrucan
|
10 mg/mL (1g/100 mL)
|
Solution for Injection for I.V. Infusion
|
-
|
Osel İlaç San. Ve Tic. A.Ş.
|
Turkey
|
Initial (Re-application)
|
04 January 2023
|
04 January 2028
|
| View |
|
DRHR-2188
|
Isopropyl Alcohol
|
Pureform
|
70 % (v/v)
|
Solution
|
-
|
Christian Cosmetic Science Inc.
|
Philippines
|
Initial
|
10 January 2023
|
10 January 2025
|
| View |
|
THPR-52
|
Hedera helix L.(Ivy Leaf Extract)
|
Prospan
|
35mg/5mL
|
Syrup
|
-
|
Engelhard Arzneimittel GmbH & Co. KG
|
Germany
|
Initial
|
05 July 2021
|
05 July 2026
|
| View |
|
DRP-9828
|
Butamirate Citrate
|
Saphmirate-T50
|
50 mg
|
Sustained-Release Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial (OTC)
|
17 June 2021
|
17 June 2026
|
| View |
|
DRP-163-04
|
Multivitamins
|
Nervebest
|
Each capsule contains: Ascorbic Acid (Vitamin C) 500 mg, Nicotinamide (Vitamin B3) 50 mg, Thiamine Hydrochloride (Vitamin B1) 10 mg, Calcium Pantothenate (Vitamin B5) 10 mg, Riboflavin (Vitamin B2) 5 mg, Pyridoxine Hydrochloride (Vitamin B6) 5 mg, Cyanocobalamin (Vitamin B12) 5 mcg
|
Capsule
|
Multivitamins
|
Scheele Laboratories Phils Inc
|
Philippines
|
Renewal
|
20 January 2023
|
04 November 2027
|
| View |
|
DRP-13274
|
Metoclopramide (as hydrochloride)
|
Rafromide
|
10 mg
|
Tablet
|
-
|
Lloyd Laboratories, Inc
|
Philippines
|
-
|
19 January 2023
|
15 January 2028
|
| View |
|
DRP-12945
|
Pregabalin
|
Pregeron
|
100 mg
|
Capsule
|
Antiepileptic
|
XL Laboratories Pvt. Ltd.
|
India
|
Renewal
|
16 January 2023
|
29 July 2028
|
| View |
|
DRP-5471-01
|
Aciclovir
|
Axivir
|
800 mg
|
Tablet
|
Antiviral ( Nucleoside and nucleotide excl. reverse transcriptase inhibitor)
|
Scheele Laboratories Phils., Inc.
|
Philippines
|
Automatic Renewal
|
16 January 2023
|
22 January 2028
|
| View |
|
DRP-9762
|
Eplerenone
|
Inspra
|
50mg
|
Film-Coated Tablet
|
Aldosterone antagonist
|
Pfizer Pharmaceuticals LLC
|
U.S.A.
|
Automatic Renewal
|
09 January 2023
|
14 February 2028
|
| View |
|
BRP-040-18
|
Enoxaparin sodium
|
Carcenoxar
|
6000 IU Anti-Factor Xa (Equivalent to 60 mg) / 0.6 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
CLIDP Conversion
|
20 January 2023
|
09 December 2025
|
| View |
|
BRP-041-19
|
Enoxaparin sodium
|
Carcenoxar
|
4000 IU Anti-Factor Xa (Equivalent to 40 mg) / 0.4 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Ltd
|
India
|
CLIDP Conversion
|
20 January 2023
|
09 December 2025
|
| View |
|
DRP-667-2
|
Amoxicillin (as Trihydrate)
|
Trexil
|
125mg/5mL
|
Powder for Suspension
|
-
|
Novagen Pharmaceutical Co., Inc.
|
Philippines
|
CLIDP Conversion
|
20 January 2023
|
04 July 2027
|
| View |
|
DRP-1077-15
|
Co-Amoxiclav
|
Genoxiclav
|
625 mg Each tablet contains: Amoxicillin 500 mg, Clavulanic Acid 125 mg
|
Tablet
|
Antibacterial (Penicillin)
|
Indchemie Health Specialities Private Limited
|
India
|
Renewal
|
20 January 2023
|
07 October 2028
|
| View |
|
DRP-2836-08
|
Salbutamol + Guaifenesin
|
Ventobrox®
|
1 mg/50 mg per 5 mL
|
Syrup
|
-
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
20 January 2023
|
09 March 2026
|
| View |
|
DRP-8403-08
|
Cefuroxime (as Sodium)
|
Unbranded
|
750 mg
|
Powder for Injection (IM/IV)
|
Powder for Injection (IM/IV) 750 mg
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
Renewal
|
25 January 2024
|
15 February 2028
|
| View |
|
DRP-10631-8
|
Vancomycin (as hydrochloride)
|
None
|
1 g
|
Powder for Injection (IV)
|
-
|
Venus Remedies Limited
|
India
|
CLIDP Conversion
|
20 January 2023
|
10 November 2026
|
| View |
|
DRP-11225-02
|
Oxaliplatin
|
Lipanox
|
2 mg/mL
|
Concentrate Solution for Injection (IV Infusion)
|
-
|
Bruck Pharma Private Limited
|
India
|
CLIDP Conversion
|
20 January 2023
|
27 December 2027
|